112 related articles for article (PubMed ID: 37187020)
1. Combination of niclosamide and quinacrine inactivates Akt/HK2/Cyclin D1 axis mediated by glucose deprivation towards the inhibition of melanoma cell proliferation.
Li S; Wang D; Zheng X; Li Y; Ding C; Wang M; Ge X; Jiang J; Qiao Y; Wang Y
Biomed Pharmacother; 2023 Jul; 163():114865. PubMed ID: 37187020
[TBL] [Abstract][Full Text] [Related]
2. PI-3K/Akt signal pathway plays a crucial role in arsenite-induced cell proliferation of human keratinocytes through induction of cyclin D1.
Ouyang W; Li J; Zhang D; Jiang BH; Huang DC
J Cell Biochem; 2007 Jul; 101(4):969-78. PubMed ID: 17370311
[TBL] [Abstract][Full Text] [Related]
3. The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma
Zhou J; Jin B; Jin Y; Liu Y; Pan J
Theranostics; 2017; 7(6):1447-1462. PubMed ID: 28529629
[TBL] [Abstract][Full Text] [Related]
4. Flavopiridol and trastuzumab synergistically inhibit proliferation of breast cancer cells: association with selective cooperative inhibition of cyclin D1-dependent kinase and Akt signaling pathways.
Wu K; Wang C; D'Amico M; Lee RJ; Albanese C; Pestell RG; Mani S
Mol Cancer Ther; 2002 Jul; 1(9):695-706. PubMed ID: 12479366
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-inducible factor-1 promotes cancer progression through activating AKT/Cyclin D1 signaling pathway in osteosarcoma.
Zhang B; Li YL; Zhao JL; Zhen O; Yu C; Yang BH; Yu XR
Biomed Pharmacother; 2018 Sep; 105():1-9. PubMed ID: 29807229
[TBL] [Abstract][Full Text] [Related]
6. Malignant growth of arsenic-transformed cells depends on activated Akt induced by reactive oxygen species.
Lou Q; Chen F; Li B; Zhang M; Yin F; Liu X; Zhang Z; Zhang X; Fan C; Gao Y; Yang Y
Int J Environ Health Res; 2023 Mar; 33(3):284-298. PubMed ID: 34974760
[TBL] [Abstract][Full Text] [Related]
7. SHP2 promotes proliferation of breast cancer cells through regulating Cyclin D1 stability
Yuan Y; Fan Y; Gao Z; Sun X; Zhang H; Wang Z; Cui Y; Song W; Wang Z; Zhang F; Niu R
Cancer Biol Med; 2020 Aug; 17(3):707-725. PubMed ID: 32944401
[No Abstract] [Full Text] [Related]
8. miR-18a promotes cell proliferation of esophageal squamous cell carcinoma cells by increasing cylin D1 via regulating PTEN-PI3K-AKT-mTOR signaling axis.
Zhang W; Lei C; Fan J; Wang J
Biochem Biophys Res Commun; 2016 Aug; 477(1):144-149. PubMed ID: 27291152
[TBL] [Abstract][Full Text] [Related]
9. Low doses of niclosamide and quinacrine combination yields synergistic effect in melanoma via activating autophagy-mediated p53-dependent apoptosis.
Zheng X; Zhang J; Li S; Gao X; Zhang Y; Wang M; Dong L; Sun L; Zhao N; Ma Z; Ding C; Wang Y
Transl Oncol; 2022 Jul; 21():101425. PubMed ID: 35460941
[TBL] [Abstract][Full Text] [Related]
10. Methylthioadenosine (MTA) inhibits melanoma cell proliferation and in vivo tumor growth.
Andreu-Pérez P; Hernandez-Losa J; Moliné T; Gil R; Grueso J; Pujol A; Cortés J; Avila MA; Recio JA
BMC Cancer; 2010 Jun; 10():265. PubMed ID: 20529342
[TBL] [Abstract][Full Text] [Related]
11. Omethoate induces pharyngeal cancer cell proliferation and G1/S cell cycle progression by activation of Akt/GSK-3β/cyclin D1 signaling pathway.
Huo D; Jiang S; Qin Z; Feng Y; Yang R; Lv L; Li Y
Toxicology; 2019 Nov; 427():152298. PubMed ID: 31574243
[TBL] [Abstract][Full Text] [Related]
12. UVA-induced cell cycle progression is mediated by a disintegrin and metalloprotease/epidermal growth factor receptor/AKT/Cyclin D1 pathways in keratinocytes.
He YY; Council SE; Feng L; Chignell CF
Cancer Res; 2008 May; 68(10):3752-8. PubMed ID: 18483258
[TBL] [Abstract][Full Text] [Related]
13. Repurposing of the anti-helminthic drug niclosamide to treat melanoma and pulmonary metastasis via the STAT3 signaling pathway.
Zhu Y; Zuo W; Chen L; Bian S; Jing J; Gan C; Wu X; Liu H; Su X; Hu W; Guo Y; Wang Y; Ye T
Biochem Pharmacol; 2019 Nov; 169():113610. PubMed ID: 31465777
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Rac1 activity induces G1/S phase arrest through the GSK3/cyclin D1 pathway in human cancer cells.
Liu L; Zhang H; Shi L; Zhang W; Yuan J; Chen X; Liu J; Zhang Y; Wang Z
Oncol Rep; 2014 Oct; 32(4):1395-400. PubMed ID: 25109327
[TBL] [Abstract][Full Text] [Related]
15. Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway.
Ong CS; Zhou J; Ong CN; Shen HM
Cancer Lett; 2010 Dec; 298(2):167-75. PubMed ID: 20655656
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor β inhibits platelet derived growth factor-induced vascular smooth muscle cell proliferation via Akt-independent, Smad-mediated cyclin D1 downregulation.
Martin-Garrido A; Williams HC; Lee M; Seidel-Rogol B; Ci X; Dong JT; Lassègue B; Martín AS; Griendling KK
PLoS One; 2013; 8(11):e79657. PubMed ID: 24236150
[TBL] [Abstract][Full Text] [Related]
17. Reprogramming induced by isoliquiritigenin diminishes melanoma cachexia through mTORC2-AKT-GSK3β signaling.
Chen XY; Li DF; Han JC; Wang B; Dong ZP; Yu LN; Pan ZH; Qu CJ; Chen Y; Sun SG; Zheng QS
Oncotarget; 2017 May; 8(21):34565-34575. PubMed ID: 28410220
[TBL] [Abstract][Full Text] [Related]
18. Targeting the AKT/GSK3β/cyclin D1/Cdk4 survival signaling pathway for eradication of tumor radioresistance acquired by fractionated radiotherapy.
Shimura T; Kakuda S; Ochiai Y; Kuwahara Y; Takai Y; Fukumoto M
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):540-8. PubMed ID: 21398050
[TBL] [Abstract][Full Text] [Related]
19. Dual c-Jun N-terminal kinase-cyclin D1 and extracellular signal-related kinase-c-Jun disjunction in human melanoma.
Pathria G; Garg B; Garg K; Wagner C; Wagner SN
Br J Dermatol; 2016 Dec; 175(6):1221-1231. PubMed ID: 27145925
[TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
